Syndromes of Neurodegeneration With Brain Iron Accumulation

Gregory, 2009, Clinical and genetic delineation of neurodegeneration with brain iron accumulation [abstract], J Med Genet, 46, 73, 10.1136/jmg.2008.061929

Hayflick, 2003, Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome, N Engl J Med, 348, 33, 10.1056/NEJMoa020817

Schneider, 2006, Severe tongue protrusion dystonia: Clinical syndromes and possible treatment, Neurology, 67, 940, 10.1212/01.wnl.0000237446.06971.72

Marelli, 2005, Clinical and neuropsychological correlates in two brothers with pantothenate kinase-associated neurodegeneration, Mov Disord, 20, 208, 10.1002/mds.20282

Bozi, 2009, A patient with pantothenate kinase-associated neurodegeneration and supranuclear gaze palsy, Clin Neurol Neurosurg, 111, 688, 10.1016/j.clineuro.2009.04.007

Antonini, 2006, Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration, Mov Disord, 21, 417, 10.1002/mds.20774

Aggarwal, 2010, Indian-subcontinent NBIA: Unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms, Mov Disord, 25, 1424, 10.1002/mds.23095

Yoon, 2010, Novel PANK2 gene mutations in Korean patient with pantothenate kinase-associated neurodegeneration presenting unilateral dystonic tremor, Mov Disord, 25, 245, 10.1002/mds.22891

Chung, 2008, Focal hand dystonia in a patient with PANK2 mutation, Mov Disord, 23, 466, 10.1002/mds.21880

Schenck, 2004, High-field magnetic resonance imaging of brain iron: Birth of a biomarker?, NMR Biomed, 17, 433, 10.1002/nbm.922

Stankiewicz, 2007, Iron in chronic brain disorders: Imaging and neurotherapeutic implications, Neurotherapeutics, 4, 371, 10.1016/j.nurt.2007.05.006

Hayflick, 2001, Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome, Pediatr Neurol, 25, 166, 10.1016/S0887-8994(01)00296-X

Chiapparini, 2011, The “eye-of-the-tiger” sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration, Neuropediatrics, 42, 159, 10.1055/s-0031-1285925

Delgado, 2012, Missense PANK2 mutation without “eye of the tiger” sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN), J Magn Reson Imaging, 35, 788, 10.1002/jmri.22884

Schneider, 2009, Iron accumulation in syndromes of neurodegeneration with brain accumulation—Causative or consequential?, J Neurol Neurosurg, Psychiatry, 80, 589, 10.1136/jnnp.2008.169953

Awasthi, 2010, Diffusion tensor MR imaging in children with pantothenate kinase-associated neurodegeneration with brain iron accumulation and their siblings, Am J Neuroradiol, 31, 442, 10.3174/ajnr.A1849

Cossu, 2005, [123I]FP-CIT SPECT findings in two patients with Hallervorden-Spatz disease with homozygous mutation in PANK2 gene, Neurology, 64, 167, 10.1212/01.WNL.0000148577.62644.77

Hermann, 2000, Hallervorden-Spatz disease: findings in the nigrostriatal system [in German], Nervenarzt, 71, 660, 10.1007/s001150050643

Doi, 2010, Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: Clinical features and (99m)Tc-ECD brain perfusion SPECT findings, J Neurol Sci, 290, 172, 10.1016/j.jns.2009.11.008

Liman, 2012, Transcranial ultrasound in neurodegeneration with brain iron accumulation (NBIA), Eur J Paediatr Neurol, 16, 175, 10.1016/j.ejpn.2011.07.009

Kruer, 2011, Novel histopathologic findings in molecularly confirmed pantothenate kinase-associated neurodegeneration, Brain, 134, 947, 10.1093/brain/awr042

Saito, 2000, Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course, J Neurol Sci, 177, 48, 10.1016/S0022-510X(00)00337-3

Neumann, 2000, Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies, Acta Neuropathol, 100, 568, 10.1007/s004010000224

Galvin, 2000, Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology, Am J Pathol, 157, 361, 10.1016/S0002-9440(10)64548-8

Williamson, 1982, Neuroaxonal dystrophy in young adults: A clinicopathological study of two unrelated cases, Ann Neurol, 11, 335, 10.1002/ana.410110403

Eidelberg, 1987, Adult onset Hallervorden–Spatz disease with neurofibrillary pathology, Brain, 110, 993, 10.1093/brain/110.4.993

Hartig, 2006, Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation, Ann Neurol, 59, 248, 10.1002/ana.20771

Lin, 2006, Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases, Nature, 443, 787, 10.1038/nature05292

Kotzbauer, 2005, Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2, J Neurosci, 25, 689, 10.1523/JNEUROSCI.4265-04.2005

Poli, 2010, Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation, Neurobiol Dis, 39, 204, 10.1016/j.nbd.2010.04.009

Castelnau, 2005, Pallidal stimulation improves pantothenate kinase-associated neurodegeneration, Ann Neurol, 57, 738, 10.1002/ana.20457

Mikati, 2009, Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration, Eur J Paediatr Neurol, 13, 61, 10.1016/j.ejpn.2008.01.006

Krause, 2006, Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration, Mov Disord, 21, 2255, 10.1002/mds.21166

Szumowski, 2010, Measurement of brain iron distribution in Hallevorden-Spatz syndrome, J Magn Reson Imaging, 31, 482, 10.1002/jmri.22031

Lim, 2012, Pantothenate kinase-associated neurodegeneration in Korea: Recurrent R440P mutation in PANK2 and outcome of deep brain stimulation, Eur J Neurol, 19, 556, 10.1111/j.1468-1331.2011.03589.x

Air, 2011, Deep brain stimulation in children: Experience and technical pearls, J Neurosurg Pediatr, 8, 566, 10.3171/2011.8.PEDS11153

Timmermann, 2010, Dystonia in neurodegeneration with brain iron accumulation: Outcome of bilateral pallidal stimulation, Brain, 133, 701, 10.1093/brain/awq022

Mylius, 2009, Low-frequency rTMS of the premotor cortex reduces complex movement patterns in a patient with pantothenate kinase-associated neurodegenerative disease (PKAN), Neurophysiol Clin, 39, 27, 10.1016/j.neucli.2008.12.003

Rana, 2010, Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration, Proc Natl Acad Sci U S A, 107, 6988, 10.1073/pnas.0912105107

Morgan, 2006, PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron, Nat Genet, 38, 752, 10.1038/ng1826

Paisan-Ruiz, 2009, Characterization of PLA2G6 as a locus for dystonia-Parkinsonism, Ann Neurol, 65, 19, 10.1002/ana.21415

Gregory, 2009, Clinical and genetic delineation of neurodegeneration with brain iron accumulation, J Med Genet, 46, 73, 10.1136/jmg.2008.061929

Paisan-Ruiz, 2012, Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations, Neurobiol Aging, 33, 814, 10.1016/j.neurobiolaging.2010.05.009

Malik, 2008, Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations, Am J Pathol, 172, 406, 10.2353/ajpath.2008.070823

Adibhatla, 2008, Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies, BMB Rep, 41, 560, 10.5483/BMBRep.2008.41.8.560

Adibhatla, 2010, Lipid oxidation and peroxidation in CNS health and disease: From molecular mechanisms to therapeutic opportunities, Antioxid Redox Signal, 12, 125, 10.1089/ars.2009.2668

Engel, 2011, Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-Parkinsonism, PLoS ONE, 5, e12897, 10.1371/journal.pone.0012897

Vinters, 1998, Diagnostic Neuropathology, 502

Cowen, 1963, Infantile neuroaxonal dystrophy, J Neuropathol Exp Neurol, 22, 175, 10.1097/00005072-196304000-00001

Kruer, 2010, Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA), Ann Neurol, 68, 611, 10.1002/ana.22122

Schneider, 2010, Three faces of the same gene: FA2H links neurodegeneration with brain iron accumulation, leukodystrophies, and hereditary spastic paraplegias, Ann Neurol, 68, 575, 10.1002/ana.22211

Dick, 2010, Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35), Hum Mutat, 31, E1251, 10.1002/humu.21205

Edvardson, 2008, Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia, Am J Hum Genet, 83, 643, 10.1016/j.ajhg.2008.10.010

Garone, 2011, FA2H-related disorders: A novel c.270+3A>T splice-site mutation leads to a complex neurodegenerative phenotype, Dev Med Child Neurol, 53, 958, 10.1111/j.1469-8749.2011.03993.x

Pierson, 2012, Exome sequencing and SNP analysis detect novel compound heterozygosity in fatty acid hydroxylase-associated neurodegeneration, Eur J Hum Genet, 20, 476, 10.1038/ejhg.2011.222

Bras, 2008, Potential role of ceramide metabolism in Lewy Body disease, Eur J Biochem (FEBS), 275, 5767

Potter, 2011, Central nervous system dysfunction in a mouse model of Fa2h deficiency, Glia, 59, 1009, 10.1002/glia.21172

Hartig, 2011, Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation, Am J Hum Genet, 89, 543, 10.1016/j.ajhg.2011.09.007

Najim al-Din, 1994, Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome, Acta Neurol Scand, 89, 347, 10.1111/j.1600-0404.1994.tb02645.x

Ramirez, 2006, Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase, Nat Genet, 38, 1184, 10.1038/ng1884

Crosiers, 2011, Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation, Parkinsonism Relat Disord, 17, 135, 10.1016/j.parkreldis.2010.10.011

Di Fonzo, 2007, ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease, Neurology, 68, 1557, 10.1212/01.wnl.0000260963.08711.08

Eiberg H, Hansen L, Korbo L, et al: Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9). Clin Genet (in press)

Ning, 2008, PARK9-linked parkinsonism in eastern Asia: Mutation detection in ATP13A2 and clinical phenotype, Neurology, 70, 1491, 10.1212/01.wnl.0000310427.72236.68

Park, 2011, Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset Parkinsonism, Hum Mutat, 32, 956, 10.1002/humu.21527

Santoro, 2011, Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability, Neurogenetics, 12, 33, 10.1007/s10048-010-0259-0

Williams, 2005, Kufor Rakeb disease: Autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia, Mov Disord, 20, 1264, 10.1002/mds.20511

Behrens, 2010, Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations, Mov Disord, 25, 1929, 10.1002/mds.22996

Machner, 2010, Eye movement disorders in ATP13A2 mutation carriers (PARK9), Mov Disord, 25, 2687, 10.1002/mds.23352

Schneider, 2010, ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation, Mov Disord, 25, 979, 10.1002/mds.22947

Brüggemann, 2010, Recessively inherited parkinsonism: Effect of ATP13A2 mutations on the clinical and neuroimaging phenotype, Arch Neurol, 67, 1357, 10.1001/archneurol.2010.281

Chien, 2011, ATP13A2-related neurodegeneration (PARK9) without evidence of brain iron accumulation, Mov Disord, 26, 1364, 10.1002/mds.23514

Paisán-Ruiz, 2010, Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations, Mov Disord, 25, 1791, 10.1002/mds.23221

Tan, 2011, Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein, J Biol Chem, 286, 29654, 10.1074/jbc.M111.233874

Wohlke, 2011, A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan Terrier, PLoS Genet, 7, e1002304, 10.1371/journal.pgen.1002304

Bras, 2012, Mutation of the parkinsonism Gene ATP13A2 causes neuronal ceroid-lipofuscinosis, Hum Mol Genet, 10.1093/hmg/dds089

Ogimoto, 2011, Criteria for early identification of aceruloplasminemia, Intern Med, 50, 1415, 10.2169/internalmedicine.50.5108

McNeill, 2008, The neurological presentation of ceruloplasmin gene mutations, Eur Neurol, 60, 200, 10.1159/000148691

Chinnery, 2007, Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation, Brain, 130, 110, 10.1093/brain/awl319

Chinnery, 1993, Neuroferritinopathy

Chinnery, 2003, Neuroferritinopathy in a French family with late onset dominant dystonia, J Med Genet, 40, e69, 10.1136/jmg.40.5.e69

Kubota, 2008, A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: Description of clinical features and implications for genotype-phenotype correlations, Mov Disord, 24, 441, 10.1002/mds.22435

McNeill, 2008, T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation, Neurology, 70, 1614, 10.1212/01.wnl.0000310985.40011.d6

Mancuso, 2005, Hereditary ferritinopathy: A novel mutation, its cellular pathology, and pathogenetic insights, J Neuropathol Exp Neurol, 64, 280, 10.1093/jnen/64.4.280

Brueggemann, 2011, Idiopathic NBIA—Clinical spectrum and transcranial sonography findings, Eur J Neurol, 18, e58, 10.1111/j.1468-1331.2010.03298.x

Waldvogel, 1999, Increased iron in the dentate nucleus of patients with Friedrich's ataxia, Ann Neurol, 46, 123, 10.1002/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H

Levy, 2007, Superficial siderosis: A case report and review of the literature, Nat Clin Pract Neurol, 3, 54, 10.1038/ncpneuro0356

Davie, 1997, Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome, Mov Disord, 12, 767, 10.1002/mds.870120525

Molinuevo, 1999, The eye of the tiger sign in cortical-basal ganglionic degeneration, Mov Disord, 14, 169, 10.1002/1531-8257(199901)14:1<169::AID-MDS1033>3.0.CO;2-#

Santillo, 2009, Frontotemporal dementia-amyotrophic lateral sclerosis complex is simulated by neurodegeneration with brain iron accumulation, Alzheimer Dis Assoc Disord, 23, 298, 10.1097/WAD.0b013e3181a2b76b

Abbruzzese, 2011, A pilot trial of deferiprone for neurodegeneration with brain iron accumulation, Haematologica, 96, 1708, 10.3324/haematol.2011.043018